About Genexol > Overview > History
1989 Cell Line development - Collaboration with ESCA genetics
1993 Process development
1995 Successful scale-up of Genexol® production process in pilot scale
1996 Optimization of Genexol® production process
Groundbreaking of Genexol® production Daejeon plant
1997 Daejeon plant completed
Product approval in Korea for manufacture and export of Genexol®
1999 ISO 9002 approval - Number : K981008
DMF filing - Number : 14338
1958 NCI Screening
1963 Discovery of paclitaxel (Wani & Wall)
1979 Action mechanism
1983 Phase I
1985 Phase II
1990 Phase III
1992 FDA approval for ovarian cancer
1994 FDA approval for breast cancer
1995 Semi-synthesis
1997 FDA approval for Kaposi's sarcoma
1999 FDA Approval for Non-Small Cell Lung Cancer